JPMORGAN CHASE & CO - APTEVO THERAPEUTICS INC ownership

APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L108. A total of 54 filers reported holding APTEVO THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of APTEVO THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$0400
+300.0%
0.00%
Q3 2019$0
-100.0%
100
-85.7%
0.00%
Q2 2019$1,0000.0%6990.0%0.00%
Q1 2019$1,0000.0%6990.0%0.00%
Q4 2018$1,000
-99.7%
699
-99.1%
0.00%
Q3 2018$388,000
-73.2%
76,339
-73.7%
0.00%
Q2 2018$1,449,000
+74.2%
290,313
+14.2%
0.00%
Q1 2018$832,000
+245.2%
254,282
+346.6%
0.00%
Q4 2017$241,000
+1105.0%
56,941
+497.2%
0.00%
Q2 2017$20,0009,5350.00%
Other shareholders
APTEVO THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Sessa Capital IM, L.P. 974,492$2,495,0000.55%
Perceptive Advisors 988,133$2,530,0000.16%
STRATEGIC INVESTMENT MANAGEMENT, LLC 38,860$99,0000.07%
Laurel Wealth Advisors, Inc. 42,890$110,0000.05%
CSS LLC/IL 353,977$906,0000.04%
GLG Partners LP 396,486$1,015,0000.03%
Capital Impact Advisors, LLC 12,318$32,0000.01%
Spark Investment Management LLC 66,000$168,0000.01%
Peak Asset Management, LLC 10,000$26,0000.01%
OXFORD ASSET MANAGEMENT LLP 99,390$254,0000.01%
View complete list of APTEVO THERAPEUTICS INC shareholders